PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Actinium Pharmaceuticals, Inc. (ATNM)
1.780.01 (-0.56%)
1.75 - 1.81
1.03 - 2.41
122.5K / 296.7K (Avg.)
-1.36 | -1.31
Identifies how quickly the company is scaling its balance sheet (via acquisitions, expansions, or debt). Strong growth, accompanied by sound fundamentals, can support long-term intrinsic value—while disproportionate debt expansion or bloated intangible assets can signal elevated risk.
-31.05%
Both companies show declining cash positions (-31.05% vs GNPX's -14.10%). Seth Klarman would examine if this reflects broader market conditions or operational challenges.
No Data
No Data available this quarter, please select a different quarter.
-31.05%
Cash + STI yoy ≥ 1.5x GNPX's -14.10%. David Dodd might see it as a strategic cash buffer advantage. Evaluate deployment plans.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
0.05%
Other current assets growth < half of GNPX's -31.23%. David Dodd sees a leaner approach to short-term items.
-31.37%
≥ 1.5x GNPX's -14.76%. David Dodd might see a short-term liquidity advantage or potential underutilized capital.
76.50%
≥ 1.5x GNPX's 12.53%. David Dodd sees more aggressive capex. Confirm it's not overspending.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
9.08%
≥ 1.5x GNPX's 2.65%. David Dodd sees significantly higher long-term asset buildup. Confirm synergy with strategy.
No Data
No Data available this quarter, please select a different quarter.
-30.47%
≥ 1.5x GNPX's -14.29%. David Dodd notes a larger balance sheet expansion. Confirm it's not overleveraged.
-21.72%
Less than half of GNPX's 88.13%. David Dodd sees a more disciplined AP approach or lower volume.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-21.72%
Less than half of GNPX's 88.13%. David Dodd sees a more disciplined short-term liability approach.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-21.72%
Less than half of GNPX's 88.13%. David Dodd sees far fewer liability expansions relative to competitor.
0.01%
Less than half of GNPX's 8.46%. David Dodd sees fewer share issuances vs. competitor.
-3.53%
Below half GNPX's -9.03%. Michael Burry suspects major net losses or high dividends vs. competitor.
-5.52%
Less than half of GNPX's -100.00%. David Dodd sees fewer intangible or market-driven swings than competitor.
No Data
No Data available this quarter, please select a different quarter.
-33.13%
≥ 1.5x GNPX's -16.73%. David Dodd sees stronger capital base growth than competitor.
-30.47%
≥ 1.5x GNPX's -14.29%. David Dodd sees faster overall balance sheet growth than competitor.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
31.05%
Above 1.5x GNPX's 14.10%. Michael Burry sees a major gap in net debt growth. Check coverage and liquidity.